EUVIMEDEUVIMED entdecken
Crossref

Serine Hydroxymethyltransferase in Cancer Cells

L. A. Gavriliuk

Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry · 2025-12 · 19 (4) · 336-351

DOI: 10.1134/s1990750824601371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, online erschienen am 02.03.2026. Verfasst von L. A. Gavriliuk. Die Arbeit nennt 108 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gavriliuk, L. A. (2025). Serine Hydroxymethyltransferase in Cancer Cells. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 19(4), 336-351. https://doi.org/10.1134/s1990750824601371

Vancouver

Gavriliuk LA. Serine Hydroxymethyltransferase in Cancer Cells. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 2025;19(4):336-351. doi:10.1134/s1990750824601371

BibTeX
@article{Gavriliuk2025,
  author = {Gavriliuk, L. A.},
  title = {Serine Hydroxymethyltransferase in Cancer Cells},
  journal = {Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry},
  year = {2025},
  volume = {19},
  number = {4},
  pages = {336--351},
  doi = {10.1134/s1990750824601371}
}
Kostenlos starten →